448 related articles for article (PubMed ID: 2420903)
21. Clinical and bacteriological effects of rifampicin in combination with L73A in leprosy: observation for six months.
Innami S; Leguizamón OR; Alvarenga AE
Lepr Rev; 1975 Jun; 46(2 Suppl):169-72. PubMed ID: 1100957
[No Abstract] [Full Text] [Related]
22. A overview of ocular leprosy after 2 decades of multidrug therapy.
Lewallen S; Courtright P
Int Ophthalmol Clin; 2007; 47(3):87-101. PubMed ID: 17667278
[No Abstract] [Full Text] [Related]
23. [New WHO recommendations for the treatment of leprosy].
Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
[No Abstract] [Full Text] [Related]
24. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
[TBL] [Abstract][Full Text] [Related]
25. Experimental chemotherapy in leprosy, then and now.
Shepard CC
Int J Lepr Other Mycobact Dis; 1973; 41(3):307-19. PubMed ID: 4136732
[No Abstract] [Full Text] [Related]
26. Chemotherapy of leprosy in multibacillary nude mice.
Hastings RC; Chehl SK
Indian J Lepr; 1991; 63(3-4):350-5. PubMed ID: 1804889
[No Abstract] [Full Text] [Related]
27. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy of leprosy for control programmes: scientific basis and practical application.
Rees RJ
Lepr Rev; 1983 Jun; 54(2):81-7. PubMed ID: 6888143
[No Abstract] [Full Text] [Related]
29. Comments on an editorial by B. R. Chatterjee "On Multi-Drug Combinations in the Treatment of Leprosy".
Grosset JH; Baohang J; Noordeen SK
Indian J Lepr; 1989 Jul; 61(3):323-7. PubMed ID: 2768880
[No Abstract] [Full Text] [Related]
30. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
Matsuoka M; Kashiwabara Y; Namisato M
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
[TBL] [Abstract][Full Text] [Related]
31. Concepts behind the development of multiple drug therapy regimens in leprosy.
Waters MF
Ethiop Med J; 1986 Dec; 24 Suppl 1():61-7. PubMed ID: 3301333
[No Abstract] [Full Text] [Related]
32. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
33. [Therapy of leprosy today].
Bahmer FA; Menzel S
Hautarzt; 1987 Jan; 38(1):1-3. PubMed ID: 3557977
[TBL] [Abstract][Full Text] [Related]
34. Multidrug therapy regimen for leprosy.
Firooz A
J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
[No Abstract] [Full Text] [Related]
35. Treatment of Hansen's disease.
Alto WA
Am Fam Physician; 2002 Apr; 65(7):1280, 1282; author reply 1282. PubMed ID: 11996412
[No Abstract] [Full Text] [Related]
36. Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York.
Levis WR; Spencer TI; Ladizinski B
J Drugs Dermatol; 2010 Aug; 9(8):906. PubMed ID: 20684139
[No Abstract] [Full Text] [Related]
37. Newer drugs in leprosy.
Grosset JH
Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S14-8. PubMed ID: 11757174
[TBL] [Abstract][Full Text] [Related]
38. Antileprosy drugs, pregnancy and fetal outcome.
Bhargava P; Kuldeep CM; Mathur NK
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):457-8. PubMed ID: 9030117
[No Abstract] [Full Text] [Related]
39. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
Pai VV; Bulchand HO; Revankar CR; Ganapati R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
[No Abstract] [Full Text] [Related]
40. Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
Williams DL; Araujo S; Stryjewska BM; Scollard D
Emerg Infect Dis; 2018 Aug; 24(8):1584-1585. PubMed ID: 30016255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
